The use of TNF-α, KJ-Pyr-9, dexamethasone, and PDTC in parallel did not impair NSCLC-derived LCSC-like cell survival synergistically (Figure 7A,B). The gene discussed is TNF; the disease is non-small cell lung carcinoma.